// App-Quantinova.ai

582 2014 ATVB : Inflammatory Cytokines Reduce Thrombin Activatable Fibrinolysis Inhibitor Protein Levels in HepG2 Cells via TTP-Mediated Destabilization of TAFI mRNA

Researchers

Presenter

  • Michael B Boffa

Principal Investigators

  • N/A

Medical Centers

  • University of Windsor, Windsor, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

  • Cytokine

  • Interleukin 1

  • Interleukin 10

  • Interleukin 6

  • Thrombin-activatable fibrinolysis inhibitor

  • Tumor necrosis factor

Drug/Treatment

  • Evithrom

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved